1. Disodium ascorbyl phytostanol phosphate. A new cholesterol-lowering drug?

   • K. von Bergmann

   Editorial Commentary 06 May 2008 Pages: 649 - 650

2. Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia

   • Maud N. Vissers
   • Mieke D. Trip
   • John J. P. Kastelein

   Clinical Trial Open access 05 March 2008 Pages: 651 - 661

   

3. Impact of genetic polymorphisms of leptin and TNF-α on rosiglitazone response in Chinese patients with type 2 diabetes

   • Hai-Ling Liu
   • Yang-Gen Lin
   • Zhao-Qian Liu

   Pharmacogenetics 26 April 2008 Pages: 663 - 671

   

4. Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

   • L. G. Possuelo
   • J. A. Castelan
   • A. Zaha

   Pharmacogenetics 18 April 2008 Pages: 673 - 681

   

5. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers

   • Catherine Orrell
   • Francesca Little
   • Karen I. Barnes

   Pharmacokinetics and Disposition Open access 16 April 2008 Pages: 683 - 690

   

6. The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects

   • Takeshi Kadokura
   • Martin den Adel
   • Akito Nishida

   Pharmacokinetics and Dispossition 26 April 2008 Pages: 691 - 695

   

7. Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells

   • Yan-Gang Zhou
   • Kun-Yan Li
   • Huan-De Li

   Pharmacokinetics and Disposition 14 May 2008 Pages: 697 - 703

   

8. How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach

   • Kayode Ogungbenro
   • Leon Aarons

   Pharmacokinetics and Disposition 16 May 2008 Pages: 705 - 713

   

9. Factors predicting hospital readmissions related to adverse drug reactions

   • Borja Ruiz
   • Montserrat García
   • Carmelo Aguirre

   Pharmacoepidemiology and Prescription 03 April 2008 Pages: 715 - 722

10. Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals

    • Francesco Lapi
    • Enrica Cecchi
    • Alessandro Mugelli

    Pharmacoepidemiology and Prescription 10 April 2008 Pages: 723 - 737

11. A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance

    • Michele Basso
    • Alessandra Cassano
    • Carlo Barone

    Letter to the Editors 19 March 2008 Pages: 739 - 741